B-type natriuretic peptide as a predictor of anterior wall location in patients with non-ST-elevation myocardial infarction
- PMID: 21552669
- PMCID: PMC3072005
- DOI: 10.1590/s1807-59322011000300013
B-type natriuretic peptide as a predictor of anterior wall location in patients with non-ST-elevation myocardial infarction
Abstract
Objective: Involvement of the left ventricular anterior wall in ST-elevation myocardial infarction has a worse prognosis compared with other regions. In non-ST-elevation myocardial infarction, noninvasive methods of locating the ischemic myocardial territory have been limited. The objective of this report is therefore to determine what factors are predictive of the anterior location of the ischemic myocardial territory.
Methods: This study included 170 patients with non-ST-elevation myocardial infarction. Clinical, echocardiographic, and laboratory characteristics, including B-type natriuretic peptide measured within 24 hours of hospitalization, and coronary angiographic features were analyzed.
Results: The mean age was 64.5 ± 12.3 years, and 112 of the patients were male (66%). The median follow-up was 23 months. The territory involved, as determined from the angiogram, was divided into anterior [n = 80 (47%)] regions and inferior and lateral [n = 90 (53%)] regions. Multivariate analysis showed that B-type natriuretic peptide was the only independent predictor of an anterior wall infarct [OR = 3.70 (95% CI: 1.61 - 8.53); P = 0.002] in non-STelevation myocardial infarction patients. Multivariate analysis also showed that B-type natriuretic peptide was an independent predictor of in-hospital cardiac events during index admission [OR = 5.05 (95% CI: 1.49 - 17.12); P = 0.009] and of cardiac events occurring during follow-up [HR = 1.79 (95% CI: 1.05 - 3.04); P = 0.032].
Conclusions: B-type natriuretic peptide was the only factor independently associated with anterior wall involvement in non-ST-elevation myocardial infarction, and the peptide levels upon admission predicted in-hospital and subsequent cardiac events.
Figures
Comment in
-
Caveats in the interpretation of natriuretic peptide levels.Clinics (Sao Paulo). 2011;66(8):1479-80. doi: 10.1590/s1807-59322011000800027. Clinics (Sao Paulo). 2011. PMID: 21915502 Free PMC article. No abstract available.
Similar articles
-
Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.Am J Cardiol. 2010 Apr 15;105(8):1065-9. doi: 10.1016/j.amjcard.2009.12.003. Epub 2010 Feb 20. Am J Cardiol. 2010. PMID: 20381654 Clinical Trial.
-
The predictive value of M30 and oxidative stress for left ventricular remodeling in patients with anterior ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.Coron Artery Dis. 2016 Dec;27(8):690-695. doi: 10.1097/MCA.0000000000000416. Coron Artery Dis. 2016. PMID: 27479531
-
Association of serum cystatin C levels with myocardial perfusion and cardiac functional recovery in patients with anterior wall ST elevation myocardial infarction treated with primary coronary intervention.Heart Vessels. 2016 Sep;31(9):1456-66. doi: 10.1007/s00380-015-0764-z. Epub 2015 Oct 23. Heart Vessels. 2016. PMID: 26498756
-
In-hospital prognostic value of admission plasma B-type natriuretic peptide levels in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction.Turk Kardiyol Dern Ars. 2011 Oct;39(7):540-8. doi: 10.5543/tkda.2011.01610. Turk Kardiyol Dern Ars. 2011. PMID: 21983763
-
Cardiac Biomarkers for the Prediction, Discrimination, and Risk-Stratification of Type 2 Myocardial Infarction: A Critical Appraisal.Am J Med. 2025 Apr 26:S0002-9343(25)00239-6. doi: 10.1016/j.amjmed.2025.04.024. Online ahead of print. Am J Med. 2025. PMID: 40294880 Review.
Cited by
-
Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction.Clinics (Sao Paulo). 2013 Jan;68(1):75-80. doi: 10.6061/clinics/2013(01)oa12. Clinics (Sao Paulo). 2013. PMID: 23420161 Free PMC article.
-
The association between myocardial early systolic lengthening and high risk angiographic territory involvement in patients with non-ST-segment elevation myocardial infarction.J Ultrasound. 2024 Sep;27(3):567-577. doi: 10.1007/s40477-024-00885-w. Epub 2024 Mar 29. J Ultrasound. 2024. PMID: 38551782
-
BNP and admission glucose as in-hospital mortality predictors in non-ST elevation myocardial infarction.ScientificWorldJournal. 2012;2012:397915. doi: 10.1100/2012/397915. Epub 2012 Feb 1. ScientificWorldJournal. 2012. PMID: 22454605 Free PMC article.
-
In-hospital death in acute coronary syndrome was related to admission glucose in men but not in women.Cardiovasc Diabetol. 2012 May 17;11:47. doi: 10.1186/1475-2840-11-47. Cardiovasc Diabetol. 2012. PMID: 22553938 Free PMC article.
-
Caveats in the interpretation of natriuretic peptide levels.Clinics (Sao Paulo). 2011;66(8):1479-80. doi: 10.1590/s1807-59322011000800027. Clinics (Sao Paulo). 2011. PMID: 21915502 Free PMC article. No abstract available.
References
-
- Thanavaro S, Kleiger RE, Province MA, Hubert JW, Miller JP, Krone RJ, Oliver GC. Effect of infarct location on the in-hospital prognosis of patients with first transmural myocardial infarction. Circulation. 1982;66:742–747. - PubMed
-
- Karha J, Murphy SA, Kirtane AJ, de Lemos JA, Aroesty JM, Cannon CP, Antman EM, Braunwald E, Gibson CM TIMI Study Group. Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction. Am J Cardiol. 2003;92:913–918. 10.1016/S0002-9149(03)00969-X - DOI - PubMed
-
- Elsman P, van 't Hof AW, de Boer MJ, Suryapranata H, Borm GF, Hoorntje JC, Ottervanger JP, Gosselink AT, Dambrink JH, Zijlstra F. Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary intervention. Am Heart J. 2006;151:1239.e9",-1,"xxx/1239.e9–14. 10.1016/j.ahj.2005.12.006 - DOI - PubMed
-
- Mauri F, Gasparini M, Barbonaglia L, Santoro E, Grazia Franzosi M, Tognoni G, Rovelli F. Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial) Am J Cardiol. 1989;63:1291–1295. 10.1016/0002-9149(89)91037-0 - DOI - PubMed
-
- Kao W, Khaja F, Goldstein S, Gheorghiade M. Cardiac event rate after non-Q-wave acute myocardial infarction and the significance of its anterior location. Am J Cardiol. 1989;64:1236–1242. 10.1016/0002-9149(89)90560-2 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources